kras mutation and glutathion KRAS-Mutant Lung Cancer: Targeting Molecular Immunologic Pathways, Therapeutic Advantages and Restrictions Overcoming resistance to drugs targeting
Overcoming resistance to drugs targeting KRASG12C mutation The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer Uncovering new therapeutic targets for a common KRAS mutation behind cancer
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



